United Kingdom General Practice Research Database

United Kingdom General Practice Research Database
Name	United Kingdom General Practice Research Database
Other names	GPRD
Country	United Kingdom
Discipline	Clinical epidemiology
Started	1987
Providers	Clinical Practice Research Datalink

United Kingdom General Practice Research Database The United Kingdom General Practice Research Database was a longitudinal primary care electronic health record resource established in England and Wales that supported pharmacoepidemiology, health services research, and drug safety studies. It linked anonymized patient records from general practices to enable observational investigations into prescribing, diagnoses, and outcomes across populations. Major users included academic institutions, regulatory agencies, and pharmaceutical companies conducting studies relevant to public health, pharmacovigilance, and clinical guidelines.

History

The database originated from initiatives in the 1980s involving Royal College of General Practitioners, collaborations with National Health Service (England), and partnerships with academic centres such as University of Oxford and London School of Hygiene and Tropical Medicine. Early development drew on coding systems like Read codes and aligned with policy frameworks promoted by Department of Health and Social Care (United Kingdom) and research priorities articulated by Medical Research Council (United Kingdom). Growth in the 1990s and 2000s saw linkage efforts with registries including the Office for National Statistics mortality data and collaborations with regulatory bodies such as the Medicines and Healthcare products Regulatory Agency. Organizational transitions eventually led to successor infrastructure managed by the Clinical Practice Research Datalink.

Structure and Data Content

The resource comprised anonymized, longitudinal patient-level data captured in general practices using clinical systems supplied by vendors and governed by practice-level agreements with entities like the General Medical Council. Core content included patient demographics, consultation records, diagnostic codes drawn from Read codes, prescription records, laboratory results, and referral information referencing institutions such as NHS England trusts and community services. Data tables were organized to facilitate cohort construction, with linkage keys enabling joins to external datasets from bodies like the National Cancer Registration and Analysis Service and the Health and Social Care Information Centre. Metadata described practice-level variables, coding dictionaries, and event timestamps to support pharmacoepidemiologic study designs.

Data Access and Governance

Access processes required approval from oversight committees that reflected governance models seen in institutions such as the Health Research Authority and ethics panels linked to universities like University College London. Researchers typically submitted protocols to independent scientific advisory committees analogous to those used by the Medical Research Council (United Kingdom) and conformed to data protection legislation including provisions influenced by directives enacted by the European Commission and domestic statutes administered by the Information Commissioner's Office. Commercial access arrangements paralleled agreements used by pharmaceutical companies operating within frameworks recognized by the Association of the British Pharmaceutical Industry. Data-sharing arrangements incorporated safeguards drawn from guidance by the World Health Organization and international research ethics standards.

Research Uses and Impact

The database underpinned influential studies in medication safety examined by investigators from centres such as Imperial College London and University of Manchester, contributed to vaccine safety assessments referenced by agencies like the European Medicines Agency, and supported comparative effectiveness research used by policymakers in National Institute for Health and Care Excellence. Publications arising from the resource informed clinical practice guidelines authored by professional bodies such as the Royal College of Physicians and helped detect safety signals that prompted regulatory reviews by the Medicines and Healthcare products Regulatory Agency. Collaborative projects involved researchers affiliated with institutions including Cambridge University Hospitals and international partners like Harvard Medical School contributing to global pharmacoepidemiology literature.

Limitations and Data Quality

Limitations reflected challenges familiar to electronic record research in settings like Scotland and Wales—including variable completeness of recording, misclassification due to coding practices such as inconsistent use of Read codes, and incomplete capture of secondary care events delivered by trusts such as Guy's and St Thomas' NHS Foundation Trust. Temporal changes in software vendors and practice participation introduced selection effects comparable to those documented in registries maintained by the Danish National Patient Register. Ascertainment bias, under-recording of lifestyle variables, and uncertainty in over-the-counter medication exposure were recognized constraints requiring methodologic mitigation strategies developed in epidemiology groups at institutions like King's College London.

Related Databases and Successors

Successor and related resources include the Clinical Practice Research Datalink which integrated infrastructures and extended linkage capabilities with datasets from bodies such as the National Health Service (England) and the Office for National Statistics. Comparable international databases cited in comparative studies include the Danish National Patient Register, the Veterans Health Administration databases in the United States, and the Canadian Primary Care Sentinel Surveillance Network. Research ecosystems leveraging primary care data also engaged with disease registries like the National Diabetes Audit and cancer registries such as the National Cancer Registration and Analysis Service.

Category:Medical databases Category:Epidemiology